Victory Capital Management’s Agios Pharmaceuticals AGIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $978K | Buy |
29,414
+20,630
| +235% | +$686K | ﹤0.01% | 1862 |
|
|
2025
Q1 | $257K | Buy |
8,784
+1,964
| +29% | +$57.5K | ﹤0.01% | 2167 |
|
|
2024
Q4 | $224K | Sell |
6,820
-184
| -3% | -$6.05K | ﹤0.01% | 2202 |
|
|
2024
Q3 | $311K | Sell |
7,004
-154
| -2% | -$6.84K | ﹤0.01% | 2128 |
|
|
2024
Q2 | $309K | Sell |
7,158
-52
| -0.7% | -$2.24K | ﹤0.01% | 2092 |
|
|
2024
Q1 | $211K | Buy |
+7,210
| New | +$211K | ﹤0.01% | 2209 |
|
|
2023
Q2 | – | Sell |
-52,670
| Closed | -$1.21M | – | 2515 |
|
|
2023
Q1 | $1.21M | Sell |
52,670
-834,624
| -94% | -$19.2M | ﹤0.01% | 1595 |
|
|
2022
Q4 | $24.9M | Buy |
887,294
+109,998
| +14% | +$3.09M | 0.03% | 693 |
|
|
2022
Q3 | $22M | Buy |
+777,296
| New | +$22M | 0.03% | 763 |
|
|
2022
Q1 | – | Sell |
-12,227
| Closed | -$402K | – | 2725 |
|
|
2021
Q4 | $402K | Sell |
12,227
-40,899
| -77% | -$1.34M | ﹤0.01% | 2265 |
|
|
2021
Q3 | $2.45M | Buy |
53,126
+45,364
| +584% | +$2.09M | ﹤0.01% | 1540 |
|
|
2021
Q2 | $428K | Sell |
7,762
-1,058
| -12% | -$58.3K | ﹤0.01% | 2274 |
|
|
2021
Q1 | $455K | Sell |
8,820
-230
| -3% | -$11.9K | ﹤0.01% | 2243 |
|
|
2020
Q4 | $392K | Buy |
9,050
+1,360
| +18% | +$58.9K | ﹤0.01% | 2184 |
|
|
2020
Q3 | $269K | Buy |
7,690
+160
| +2% | +$5.6K | ﹤0.01% | 2191 |
|
|
2020
Q2 | $403K | Sell |
7,530
-7,662
| -50% | -$410K | ﹤0.01% | 2059 |
|
|
2020
Q1 | $540K | Buy |
15,192
+5,644
| +59% | +$201K | ﹤0.01% | 2066 |
|
|
2019
Q4 | $456K | Buy |
9,548
+2,888
| +43% | +$138K | ﹤0.01% | 2051 |
|
|
2019
Q3 | $216K | Buy |
+6,660
| New | +$216K | ﹤0.01% | 2195 |
|
|
2017
Q1 | – | Sell |
-6,750
| Closed | -$282K | – | 1801 |
|
|
2016
Q4 | $282K | Buy |
+6,750
| New | +$282K | ﹤0.01% | 1348 |
|